Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity

References

• WHO | Skin cancers. WHO. Available from: http://www.who.int/uv/faq/skincancer/en/ [last accessed 1 Aug 2019].
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Garbe C, Peris K, Hauschild A, et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016. Eur J Cancer 2016;63:201–17.
   PubMed Web of Science ®Google Scholar
• Kim G, McKee AE, Ning Y-M, et al. FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation. Clin Cancer Res off J Am Assoc Cancer Res 2014;20:4994–5000.
   PubMed Web of Science ®Google Scholar
• Savoia P, Fava P, Casoni F, et al. Targeting the ERK signaling pathway in melanoma. Int J Mol Sci 2019;20:1483.
   PubMed Web of Science ®Google Scholar
• Mahapatra DK, Asati V, Bharti SK. MEK inhibitors in oncology: a patent review (2015-Present). Expert Opin Ther Pat 2017;27:887–906.
   PubMed Web of Science ®Google Scholar
• Sanlorenzo M, Vujic I, Posch C, et al. Melanoma immunotherapy. Cancer Biol Ther 2014;15:665–74.
   PubMed Web of Science ®Google Scholar
• Ascierto PA, Bastholt L, Ferrucci PF, et al. The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study. Melanoma Res 2018;28:1–340.
   PubMed Web of Science ®Google Scholar
• Ascierto PA, Ferrucci PF, Fisher R, et al. Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma. Nat Med 2019;25:941–6.
   PubMed Web of Science ®Google Scholar
• Gallud A, Vaillant O, Maillard LT, et al. Imidazopyridine-fused [1,3]-diazepinones: synthesis and antiproliferative activity. Eur J Med Chem 2014;75:382–90.
   PubMed Web of Science ®Google Scholar
• Bellet V, Lichon L, Arama DP, et al. Imidazopyridine-fused [1,3]-diazepinones part 2: structure-activity relationships and antiproliferative activity against melanoma cells. Eur J Med Chem 2017;125:1225–34.
   PubMed Web of Science ®Google Scholar
• Wang J, Gao L, Lee YM, et al. Target identification of natural and traditional medicines with quantitative chemical proteomics approaches. Pharmacol Ther 2016;162:10–22.
   PubMed Web of Science ®Google Scholar
• Masurier N, Aruta R, Gaumet V, et al. Selective C-acylation of 2-aminoimidazo[1,2-a]pyridine: application to the synthesis of imidazopyridine-fused [1,3]diazepinones. J Org Chem 2012;77:3679–85.
   PubMed Web of Science ®Google Scholar
• Arama DP, Lisowski V, Scarlata E, et al. An efficient synthesis of pyrido-imidazodiazepinediones. Tetrahedron Lett 2013;54:1364–7.
   Web of Science ®Google Scholar
• Schoonen L, Pille J, Borrmann A, et al. Sortase A-mediated N-terminal modification of cowpea chlorotic mottle virus for highly efficient cargo loading. Bioconjug Chem 2015;26:2429–34.
   PubMed Web of Science ®Google Scholar
• Shang R, Fu Y, Li J-B, et al. Synthesis of aromatic esters via Pd-catalyzed decarboxylative coupling of potassium oxalate monoesters with aryl bromides and chlorides. J Am Chem Soc 2009;131:5738–9.
   PubMed Web of Science ®Google Scholar
• Wang Z-J, Wang X-Y, Wang X, et al. Carbonylative Suzuki cross-coupling reaction catalyzed by bimetallic Pd-Pt nanodendrites under ambient CO pressure. Catal Commun 2017;101:10–4.
   Web of Science ®Google Scholar
• Joseph JT, Sajith AM, Ningegowda RC, et al. Room temperature carbonylation of (hetero) aryl pentafluorobenzenesulfonates and triflates using palladium-cobalt bimetallic catalyst: dual role of cobalt carbonyl. Adv Synth Catal 2017;359:419–25.
   Web of Science ®Google Scholar
• Gialdi F, Ponci R. Antibacterial activity of derivatives of quinoline. VI. Preparation of some Schiff bases from quinoline-8-aldehyde. Farmaco Sci Tec 1951;6:327–57.
   Google Scholar
• Vincent L-A, Attaoua C, Bellis M, et al. Lysosomes and unfolded protein response, determinants of differential resistance of melanoma cells to vinca alkaloids. Fundam Clin Pharmacol 2015;29:164–77.
   PubMed Web of Science ®Google Scholar
• ENV/JM/MONO(2010)20/OECD N° 129: Guidance document on using cytotoxicity tests to estimate starting doses for acute oral systemic toxicity tests. Available from: http://www.oecd.org
   Google Scholar
• NCI Website, www.dtp.nci.nih.gov
   Google Scholar
• Drug-likeness and molecular property prediction. Available at: http://molsoft.com/mprop/ [last accessed 06 Sept 2019].
   Google Scholar
• Cummings SP, Cao Z, Fanwick PE, et al. Diruthenium(III,III) ethynyl-phenyleneimine molecular wires: preparation via on-complex schiff base condensation. Inorg Chem 2012;51:7561–8.
   PubMed Web of Science ®Google Scholar
• Pelcman B, Krog-Jensen C, Shen Y, et al. Piperidinones useful in the treatment of inflammation;Patent US20100168167A1; 01-07-2010
   Google Scholar
• Goddard-Borger ED, Stick RV. An efficient, inexpensive, and shelf-stable diazotransfer reagent: imidazole-1-sulfonyl azide hydrochloride. Org Lett 2007;9:3797–800.
   PubMed Web of Science ®Google Scholar
• Depreux P, Lesieur D, Mansour HA, et al. Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands. J Med Chem 1994;37:3231–9.
   PubMed Web of Science ®Google Scholar
• Griffin RJ. Chapter 3: the medicinal chemistry of the Azido group. In: Ellis GP, Luscombe DK, eds. Progress in medicinal chemistry. Amsterdam, The Netherlands: Elsevier; 1994:121–232.
   Google Scholar
• Yamori T. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics. Cancer Chemother Pharmacol 2003;52:74–9.
   PubMed Web of Science ®Google Scholar
• Holbeck SL, Collins JM, Doroshow JH. Analysis of FDA-approved anti-cancer agents in the NCI60 panel of human tumor cell lines. Mol Cancer Ther 2010;9:1451–60.
   PubMed Web of Science ®Google Scholar